About ALNA

Allena Pharmaceuticals, Inc. is a late-stage, clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena's lead product candidate, ALLN-177, is a first in class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ALNA is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
URTY ProShares UltraPro Russell2000 95.6 M 9.5578E+07 2,015 2015 0.0% 1.01714E-05 3 K 3103
UWM ProShares Ultra Russell2000 172.4 M 1.72382E+08 2,016 2016 0.0% 1.5353E-05 6 K 5742
VTHR Vanguard Russell 3000 ETF 422.4 M 4.224E+08 2,954 2954 0.0% 0 807 807
VTWG Vanguard Russell 2000 Growth ETF 286.3 M 2.863E+08 1,245 1245 0.01% 8E-05 22 K 22184
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.4 B 1.84016E+10 3,566 3566 0.0% 0 351 K 350556
IWC iShares Microcap ETF 886.7 M 8.86737E+08 1,452 1452 0.02% 0.0002 201 K 200583
IWM iShares Russell 2000 ETF 42.2 B 4.21588E+10 2,005 2005 0.0% 0 1.7 M 1689360
IWO iShares Russell 2000 Growth ETF 9.0 B 9.04557E+09 1,238 1238 0.01% 0.0001 720 K 719639
IWV iShares Russell 3000 ETF 9.5 B 9.51271E+09 2,930 2930 0.0% 0 46 K 45584

Wait, Before You Leave...